Petition for NHMRC to Create Gender Equity Needs Your Signature


STEMM equity statistics

A petition was published calling on medical researchers and the broader Australian scientific community to challenge the NHMRC to urgently begin a strategic overhaul of current funding programs to ensure Equitable financing for women in STEMM.

The petition is growing and has more than 1,700 signatures. Please read the petition article and support a more equitable NHMRC funding system for women in STEM, to retain women, retain diverse teams, and continue to produce diverse research for the economy. Australian knowledge by signing the petition here and sharing between your networks.

Equitably finance women in STEM

Australia’s largest government-run medical research grant funding body, the National Health and Medical Research Council (NHMRC), provides women with significantly less funding than their male counterparts in a failing system, which requires an urgent strategic overhaul to deliver equitable results to all researchers.

Australia needs a diverse and equitable research landscape to address our current and future global health challenges. ”

Career success in research depends on key parameters including: (1) research publications; (2) conference presentations and (3) successful awarding of grants. Government-funded grants and scholarships allow researchers to continue their long-term research contributions to enhance the Australian knowledge economy and provide essential career development by addressing the three key parameters to remain competitive. For many researchers, government-funded grants and scholarships are the sole source of their salaries and those of the early-career researchers they supervise, and ensure the provision of laboratory consumables, tools and technology for do their research. Lack of funding is the main driver of the loss of highly qualified and experienced researchers in academia, and also a major obstacle to promotion. These researchers continue to be disproportionately female.

“In academia, women make up about half of early career researchers (RCTs), made up of junior researchers with a doctorate or equivalent in STEMM, but the demographic ‘scissor graph’ shows that Women continue to be excluded from full participation in science, with a striking loss of women as seniority increases.

The main factor that contributes to this lack of retention of women in Science, Technology, Engineering, Mathematics and Medicine (STEMM) is that women receive fewer grants or, if funded, receive less money, due to stigma. sexist in the peer review system, which is clearly demonstrated by the recent results of the NHMRC Researcher Grant. These grants represent approximately 40% of NHMRC’s annual funding and are awarded to unique investigators, providing funding that supports salaries and consumer expenses in the researcher’s lab. The loss of funding by gender has a significant impact on the ability of women researchers to conduct research and, consequently, on the ability of women to produce the key metrics needed for promotion and retention.

“Although an equal number of grant applications were received from female and male researchers, men received a disproportionately 23% in additional grants, corresponding to an additional $ 95 million in funding awarded to men each year.”

The results of gender finance are not a new issue, but it is an issue that requires urgent change. The NHMRC must take responsibility and act now to support and improve the retention of women in STEMM.

We call on the NHMRC to improve equity for women in STEMM by allocating the same amount of funding to each gender (including a separate pot for non-binary applicants) and to set quotas at each of the scholarship levels of researcher (scholarship) for each gender to ensure that all academic levels are supported with equity. Please sign with your support for equitable funding for women in STEMM.

Best wishes

GEDI COMMITTEE of the Central Clinical School
  • PRESIDENT – Dr Jessica Borger
  • VICE-PRESIDENT- Dr Michelle Zajac
  • MANAGING DIRECTOR – Mr. Elan L’Estrange-Stranieri
  • HDR Representative – Mrs. Alexandra Dimitropoulos
  • EMCR Representative – Dr Meaghan Clough
  • Dr Catherine Carmichael
  • Dr Zhouije Ding
  • Dr Omar Ibrahim
  • Dr Scott Kolbe
  • Dr Loretta Piccenna
  • Dr Lenka Vodstrcil

We recognize the traditional owners and custodians of the lands on which we live and work and honor the elders past, present and future

About Hector Hedgepeth

Check Also

Oxford BioDynamics Checkpoint Inhibitor Response Test (EpiSwitch® CiRT) Now Available in the UK

Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for …

Leave a Reply

Your email address will not be published.